News from Eli Lilly
Stay current with all the latest and breaking news about Eli Lilly, compare headlines and perspectives between news sources on stories happening today. In total, 273 stories have been published about Eli Lilly which Ground News has aggregated in the past 3 months.
Covered Most By
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Eli Lilly News
Latest News Stories
Eli Lilly · ChinaGlobal Health Developments: New Approvals, Outages, and Outbreaks In recent health news, Eli Lilly announced that China's regulators have approved its weight loss drug, tirzepatide. This approval intensifies Eli Lilly's competition with Novo Nordisk in the Asian market. The announcement saw a 1.6% rise in the company's shares, trading at $862.39.Two German hospitals in Luebeck and Kiel canceled elective operations due to a global IT outage link…See the Story
Global Health Developments: New Approvals, Outages, and Outbreaks
Eli LillyThe skyrocketing demand for GLP-1 medications for weight loss is causing significant supply issues, often leaving type 2 diabetic patients without access to these critical drugs. GLP-1 receptor agonists are blockbuster drugs due to their dual role in managing type 2 diabetes and aiding in weight reduction. These medications induce the pancreas to produce more insulin and help curb hunger, slowing the movement of food from the stomach into the sm…See the Story
Craze For Ozempic And Zepbound For Weight Loss Leave Diabetic Patients Without Critical GLP-1 Medications - Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY)
100% Center coverage: 1 sources
Eli Lilly · ChinaBy Andrew Silver SHANGHAI (Reuters) – Eli Lilly said in a social media post Friday its weight loss drug tirzepatide had received approval from Chinese regulators, further intensifying competition with its Danish rival Novo Nordisk in the key Asian market. Novo’s weight loss drug Wegovy won approval from China, the world’s second-largest economy and the country estimated to hold the highest number of overweight or obese people, in June i…See the Story
Eli Lilly's weight loss drug tirzepatide gets approval in China
100% Center coverage: 2 sources
Eli LillyCompetition is mounting in the weight loss sector as giants like Eli Lilly, Roche, Novo Nordisk and Pfizer explore oral weight loss drugs that could be a boon to people wanting a needle-free weight loss option.See the Story
Weight Loss Pills Intensify Obesity Drug Race—But Here’s Why Experts Say Injections Aren’t Going Anywhere
100% Center coverage: 1 sources
